Introduction
The GeneChip technology has recently made rapid progress, but some important problems still remain open. For example: 1) The GeneChips are expensive, and the replication of experiments is not easy; 2) The GeneChips generate tens of thousands of data for every experiment, and a new method for handling such voluminous data efficiently is desired.
In a previous paper, 1 we put forward a method for detecting significant changes between two different conditions from a single pair of experiments, that is, treatment and control. The method is called FUMI theory (FUnction of Mutual Information). 2, 3 Under the condition of the paper, out of 12559 genes on the chip, 200 -310 genes were selected as differently expressed with 1% risk. Due to the risk of 1%, however, 126 genes must be falsely selected. This number of false positive genes is critical compared to the totally selected genes (200 -310).
The simplest solution to the problems will be to refer to the results of repeated experiments under the same conditions. 4 It is quite probable that the genes of true differences in the expression will be selected once and again by the replicates. On the other hand, the false positive genes will be selected at random, and not many times.
This paper proposes a method to make the judgment based on the FUMI theory more reliable, i.e., a method to distinguish between the true positive and false positive, even from a single pair of treatment and control experiments. For this purpose, a commercially available database which provides a biomoleculefunctional network is integrated.
Experimental
The details of experiments for the microarray analysis were previously described. 1 Human promyelocytic leukemia cell line (HL60) cells were exposed to 20 nM 12-O-tetradecanoylphorbol 13-acetate (TPA) for 9 h and biotin-labeled cRNA was prepared and stored as a stock solution for later hybridization. A total of four GeneChip arrays (Human Genome U95A set, Affymetrix, Inc) were used for hybridization (two with the TPA-exposed stock solution and two with the control stock solution). One of four combinations of exposure and control experiments was taken as an example in the text. The others were used for reference.
The network of proteins ( Fig. 1 ) was drawn with a commercial database (KeyMolnet, Institute of Medicinal Molecular Design Inc., Tokyo).
Theory
In the FUMI theory, the a priori SD, σ, of microarray fluorescence measurements is described as a function of the averaged measurements, X:
This relationship was obtained in our previous study from six replicate samples which were different from the target samples. Let XE be the expression level (measurement) of a gene for the exposed sample and XC be the measurement of the gene for the control sample. σ is given by Eq. (1) as X = |XE + XC|/2. The judgment of the significant differences is performed based on the inequality: A probabilistic test (FUMI theory) for GeneChip experiments has been proposed for selecting the genes which show significant differences in the gene expression levels between a single pair of treatment and control. This paper describes that the reliability of the judgment by the FUMI theory can be enhanced, when the selected genes are referred to biomolecular-functional networks of a commercial database. The genes judged as being differently expressed are grouped into a cluster in the biomolecular networks. It is also demonstrated that false positive genes have a trend in the networks to be isolated from each other, and also away from the clustered genes, since the false positive genes are randomly selected. where 2.58 is the critical value for a significant level of 1% under the assumption that the distribution of XE -XC is normal. If the risk is raised from 1% to 5%, the critical value becomes 1.96.
Results and Discussion
The FUMI theory provided the judgment with 1% risk that out of 12559 genes on the U95A array, 1231 genes were differently expressed between the TPA treated HL60 cells and control cells. Figure 1 illustrates the well-known pathways around the TPA receptor, PKC (protein kinase C). 5 TPA is known to promote the transcription of IL-8 (interleukin 8), TNFα (tumor necrosis factor α), and MMP-9 (matrix metalloproteinase 9) through the transcription factor, NFκB (NF kappa B). 6 In the figure, the black and gray ellipses represent the molecules for which the gene expression levels were judged to increase with 1% and 5% risks, respectively. The white ellipses denote the molecules which were judged to be unaffected by TPA. The small circles show the protein modification by phosphorylation (P) and ubiquitination (U). The arrows show the biological influence from one molecule to another. The molecules which function as a complex are grouped by the square.
The results from the significance test for one pair of experimental data (one treatment and one control) are discussed below. The tests for three other pairs of data, obtained under the same conditions, are used for corroboration. The genes on the pathways to IL-8, TNFα and MMP-9 were also judged as being affected in the other three tests, but PP2A (Protein phosphatase 2A), was not, even when the risk was increased to 5%.
From the above results, it follows that the genes selected by every significance test, e.g., the pathways to IL-8, TNFα and MMP-9, will have a high probability that the gene expression level is truly different between the treatment and control. In the protein network diagram, the selected proteins appear as a cluster.
Among the 1231 genes selected by the FUMI theory, some gene groups which are similar to the PKC cluster are also found when they are applied to protein networks, e.g., EGR-1 7 and p21 Waf1/Cip1 . 8 These genes are well-known to be induced by TPA, 7, 8 and are involved in the 753 genes which were selected from each of the four pairs of exposure and control.
On the other hand, the isolated genes from the cluster, e.g., PP2A, were selected only once from the four pairs. Therefore, PP2A was selected randomly, and can be concluded to be false positive. On the network, the false positive genes will be isolated from the clustered genes.
Among the selected 1231 genes, 97 genes were not selected by the other reference pairs of experiments, and are suspected to be false positive. They are all isolated from the PKC cluster. The number, 97, is close to the probable number of false positive genes when the risk is 1% (= 126). The number of genes suspected to be false positive is 80, 128, 129 for the reference pairs, respectively.
We can conclude that the combination of the test of significant difference (FUMI theory) with a protein network database (KeyMolnet) can substantially enhance the reliability of judgment. In other words, the true and false differences in the gene expression levels can be distinguished based on the relative position of the molecules in the protein network, i.e., clustered or isolated. This paper has taken the well-known experiment as a model example, but the proposed method will be applicable to practical problems.
The biological activities of the genes clustered in the database (KeyMolnet) can be confirmed, though not always, by literature. However, it will be quite difficult to find relevant papers on the isolated genes because of the randomness and abundance of their occurrence. Among 12559 genes, 1231 genes were selected by the FUMI theory as mentioned above. About 10000 genes can be candidates for the false positive on a gene chip and possibly only a part of these genes have been studied so far. Nevertheless, our purpose is to provide a method for estimating the unknown biological functions of the genes from the combination of insufficient information. The FUMI theory and database can play a complementary role in analyzing a huge amount of GeneChip data.
